-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to a Reuters report on the 12th, the European Medicines Agency recently listed another rare blood disease-capillary leak syndrome (CLS) as a potential side effect of AstraZeneca's new crown vaccine
.
According to reports, the European Medicines Agency Safety Committee pointed out on the 11th that AstraZeneca must list such side effects on the label
.
The committee also recommends that people who have previously experienced swelling and blood pressure drop due to CLS should not receive the AstraZeneca vaccine
The European Medicines Agency began investigating these cases in April
.
The committee reviewed six cases of CLS.
The report pointed out that the latest recommendations of the European Medicines Agency put AstraZeneca into a deeper predicament
.
Previously, many countries had reported cases of death from blood clots after inoculation with AstraZeneca vaccine, which once caused concern
According to Reuters, as of now, more than 78 million doses of AstraZeneca vaccine have been injected in European Union countries, Iceland, Norway and the United Kingdom
